Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Labetalol Safety in Patients with Pseudoseizures

Pharmacological Profile and Safety Considerations

  • Labetalol has a well-established safety profile across various hypertensive conditions and is considered a first-line agent for many hypertensive emergencies, with no known interactions or contraindications specific to patients with pseudoseizures or other psychogenic conditions 1, 2, 3

Clinical Applications Where Labetalol Excels

  • Labetalol is particularly effective for hypertensive emergencies requiring rapid but controlled blood pressure reduction, including malignant hypertension, hypertensive encephalopathy, acute ischemic stroke with elevated blood pressure, acute hemorrhagic stroke, and eclampsia and severe pre-eclampsia 1, 2, 4
  • The European Society of Cardiology recommends labetalol as a first-line treatment for multiple hypertensive emergencies, with a strength of evidence level of I (high-quality evidence) 1

Important Precautions and Contraindications

  • The American Heart Association recommends that labetalol should be used with caution in patients with a history of reactive airway disease or asthma (relative contraindication), decompensated heart failure, bradycardia or heart block, and pheochromocytoma (has been associated with acceleration of hypertension in individual cases) 4, 5, 6, 7